Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing the acceptability of contragestion among reproductive-aged women in Hong Kong.

BMJ sexual & reproductive health·2026
Same author

Evidence base to inform health service configuration for abortion provision: the SACHA (Shaping Abortion for Change) multi-component study.

Health and social care delivery research·2026
Same author

Abortion exceptionalism in research governance: why naming the problem matters.

BMJ sexual & reproductive health·2026
Same author

Advantages and disadvantages of peri-abortion ultrasonography.

Reproduction & fertility·2026
Same author

Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service.

BMJ sexual & reproductive health·2026
Same author

Improving Access to Medical Abortion Services: Results From Ghana and Cambodia.

BJOG : an international journal of obstetrics and gynaecology·2025

Related Experiment Video

Updated: May 22, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

The CPLAN study: Clotting Parameters after medicaL AbortioN.

John J Reynolds-Wright1,2, Alastair F Nimmo3, Julia A M Anderson4

  • 1Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom.

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|May 20, 2025
PubMed
Summary

Coagulation changes during early pregnancy and after medical abortion are minimal. This suggests shorter thromboprophylaxis durations may be sufficient for women at risk of venous thromboembolism (VTE).

Keywords:
Coagulationearly pregnancytermination of pregnancythromboelastometrythrombosisvenous thromboembolism

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.5K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

8.9K

Related Experiment Videos

Last Updated: May 22, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.5K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

8.9K

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Thrombosis Research

Background:

  • Limited data exists on coagulation changes throughout pregnancy, puerperium, and post-abortion.
  • Current guidance for post-abortion thromboprophylaxis is based on expert opinion and extrapolated from post-birth recommendations, with durations varying widely.
  • Understanding these coagulation dynamics is crucial for assessing venous thromboembolism (VTE) risk.

Purpose of the Study:

  • To investigate coagulation parameters in early pregnancy and following medical abortion.
  • To compare coagulation markers between pregnant women undergoing medical abortion and non-pregnant controls.
  • To inform VTE risk assessment and thromboprophylaxis guidelines post-abortion.

Main Methods:

  • A prospective study was conducted in a UK community abortion clinic.
  • Healthy pregnant women (<12 weeks gestation) and non-pregnant controls were recruited.
  • Coagulation markers (Clauss-fibrinogen, PT, aPTT, platelets) and viscoelastic measures were assessed pre- and post-abortion using the ClotPro® system.

Main Results:

  • Forty-five women (24 pregnant, 21 non-pregnant) were included.
  • Clauss-fibrinogen was slightly elevated pre-abortion compared to controls but remained within normal limits.
  • Minor pro-coagulant changes were observed in viscoelastic measures, with small absolute differences within normal ranges.

Conclusions:

  • First-trimester pregnancy and medical abortion are associated with minimal changes in coagulation parameters.
  • These coagulation changes largely resolve within 10-14 days post-abortion.
  • Shorter thromboprophylaxis durations may be adequate post-abortion compared to post-birth for individuals at high VTE risk.